Back to results
UnknownPhase 2

Melatonin for Nocturia in Parkinson's Disease

NCT02359448

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology

London, United Kingdom

Contact

Adedayo Akinyemi

a.akinyemi@ucl.ac.uk
View on ClinicalTrials.gov
Melatonin for Nocturia in Parkinson's Disease — TrialFind